Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EQS-News: Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India


EQS-News: Olympus Corp. / Key word(s): Miscellaneous
Olympus Enhances Innovation Capabilities by Expanding R to Hyderabad, India

12.06.2024 / 14:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Olympus Enhances Innovation Capabilities by Expanding R to Hyderabad, India
 

fncls.ssp?fn=download2_file&code_str=016ba4a1f00817e8a3aa042e15d14dbb

Endoscopy Engineering support services in India

 

Tokyo, Japan, 12 June 2024, JCN Newswire - Olympus Corporation (Olympus), a global MedTech Company committed to making people’s lives healthier, safer and more fulfilling, today announced its strategic initiative to establish an R Offshore Development Center (ODC) in Hyderabad, India. This decision comes as a result of a strategic agreement with global technology company HCLTech, aimed at diversifying Olympus' innovation generation activities.

Establishing this R ODC in Hyderabad is part of Olympus' commitment to leverag e global R talents and resources driving advancements in medical technology. Hyderabad is a major metropolitan area and is known as India’s MedTech hub, providing the talent needed for research and development activities necessary for Olympus' expansion efforts.

Concurrent with the creation of the ODC, Olympus will also prepare for the establishment of Olympus’ in-house R center in the coming years. This center would be in addition to the company’s current R centers in Japan, the United States, and Europe.

The company plans to further establish its presence in the country by collaborating with AIG Hospitals, Hyderabad for joint research projects. By partnering with one of India's premier healthcare institutions, Olympus aims to leverage clinical expertise and insights to drive t he development of innovative medical solutions that address the evolving needs of patients worldwide.

Since establishing Olympus Medical Systems India Private Limited in 2009, Olympus has continued to expand its operations in India and has achieved growth with the support of its many stakeholders. These strategic initiatives not only reinforce Olympus’ commitment to advancing medical technology but also strengthen its global footprint and enhance the company’s ability to deliver impactful healthcare solutions.

 

Comment from Andre Roggan, Chief Technology Officer at

“It is with great pleasure and excitement that we announce this agreement with HCLTech, with whom we share a decade-long partnership in core engineering and R services. I am confident that our collaboration will enhance Olympus’ engineering capabilities and unlock new innovations that enable quality healthcare through technology.”

 

Comment from Mr. D. Sridhar Babu, Minister of Information Technology, Electronics Communications (ITE) and Industries Commerce (I) of the Government of Telangana

We are thrilled that Olympus Corporation, one of the world's largest medical device companies, has chosen Hyderabad for its first investment in India with an R center, marking a significant milestone for our city's medical devices ecosystem. With Hyderabad's robust infrastructure, strategic location, and thriving community of innovative healthcare companies, this investment is poised to be a game-changer for the medical devices sector in India. We are confident that Olympus' advanced technologies and expertise will significantly contribute to our vision of becoming a global hub for medical device innovation and manufacturing. I welcome Olympus Corporation to our ecosystem.”

 

About HCLTech

HCLTech is a global technology company, home to more than 227,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud , and AI, powered by a broad portfolio of technology services and products. HCLTech works with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Telecom and Media, Retail and CPG, and Public Services. Consolidated revenues as of the 12 months ending March 2024 totalled $13.3 billion. To learn how HCLTech can supercharge progress for you, visit hcltech.com.

 

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit olympus-global.com and follow our global X account: @Olympus_Corp.

 

Media contact:

Mail: [email protected]  

 

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com



12.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1923725  12.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1923725&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

Olympus Corp. Stock

€15.70
-0.970%
The price for the Olympus Corp. stock decreased slightly today. Compared to yesterday there is a change of €0.28 (-0.970%).
Currently there is a rather positive sentiment for Olympus Corp. with 5 Buy predictions and 2 Sell predictions.
With a target price of 17 € there is a slightly positive potential of 8.28% for Olympus Corp. compared to the current price of 15.7 €.
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments